Literature DB >> 18248793

Cannabis use and brain structural alterations in first episode schizophrenia--a region of interest, voxel based morphometric study.

Srihari S Bangalore1, Konasale M R Prasad, Debra M Montrose, Dhruman D Goradia, Vaibhav A Diwadkar, Matcheri S Keshavan.   

Abstract

Structural alterations of the brain in schizophrenia have been associated with genetic and environmental factors. Among the environmental factors, cannabis use has been associated with increased risk for patients with schizophrenia, but the effect of cannabis on their brain structure is unclear. We examined gray matter alterations in first episode schizophrenia patients (FES) with cannabis use (FES+C; n=15) compared to FES without cannabis use (FES-C; n=24) and 42 healthy controls who did not use cannabis. We conducted a voxel based morphometric analysis of a priori determined regions of interest consisting of the CB1 receptor rich brain regions. We observed a decrease in gray matter density in the right posterior cingulate cortex (PCC) in FES+C when compared with FES-C. The results suggest that cannabis use may be associated with altered brain structure, in particular regions rich in CB1 receptors. These findings need to be confirmed by larger, prospective studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18248793     DOI: 10.1016/j.schres.2007.11.029

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  41 in total

Review 1.  Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"?

Authors:  Konasale M Prasad; Matcheri S Keshavan
Journal:  Schizophr Bull       Date:  2008-04-11       Impact factor: 9.306

2.  Associations between adolescent cannabis use and brain structure in psychosis.

Authors:  Hila Abush; Subroto Ghose; Erin A Van Enkevort; Brett A Clementz; Godfrey D Pearlson; John A Sweeney; Matcheri S Keshavan; Carol A Tamminga; Elena I Ivleva
Journal:  Psychiatry Res Neuroimaging       Date:  2018-03-28       Impact factor: 2.376

3.  Impact of substance use disorder on gray matter volume in schizophrenia.

Authors:  Margaret Quinn; Maureen McHugo; Kristan Armstrong; Neil Woodward; Jennifer Blackford; Stephan Heckers
Journal:  Psychiatry Res Neuroimaging       Date:  2018-08-03       Impact factor: 2.376

Review 4.  The role of untreated psychosis in neurodegeneration: a review of hypothesized mechanisms of neurotoxicity in first-episode psychosis.

Authors:  Kelly K Anderson; Aristotle Voineskos; Benoit H Mulsant; Tony P George; Kwame J Mckenzie
Journal:  Can J Psychiatry       Date:  2014-10       Impact factor: 4.356

Review 5.  Neuroimaging Studies in Patients With Mental Disorder and Co-occurring Substance Use Disorder: Summary of Findings.

Authors:  Kaloyan Rumenov Stoychev
Journal:  Front Psychiatry       Date:  2019-10-23       Impact factor: 4.157

Review 6.  Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models.

Authors:  Daniel T Malone; Matthew N Hill; Tiziana Rubino
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 7.  Endocannabinoid system: potential novel targets for treatment of schizophrenia.

Authors:  Atsushi Saito; Michael D L Ballinger; Mikhail V Pletnikov; Dean F Wong; Atsushi Kamiya
Journal:  Neurobiol Dis       Date:  2012-12-07       Impact factor: 5.996

Review 8.  Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis.

Authors:  Lena Palaniyappan; Nicola Maayan; Hanna Bergman; Clare Davenport; Clive E Adams; Karla Soares-Weiser
Journal:  Cochrane Database Syst Rev       Date:  2015-08-07

Review 9.  Role of cannabis and endocannabinoids in the genesis of schizophrenia.

Authors:  Emilio Fernandez-Espejo; Maria-Paz Viveros; Luis Núñez; Bart A Ellenbroek; Fernando Rodriguez de Fonseca
Journal:  Psychopharmacology (Berl)       Date:  2009-07-24       Impact factor: 4.530

10.  Altered white matter microstructure in adolescent substance users.

Authors:  Sunita Bava; Lawrence R Frank; Tim McQueeny; Brian C Schweinsburg; Alecia D Schweinsburg; Susan F Tapert
Journal:  Psychiatry Res       Date:  2009-08-20       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.